Seshu Tyagarajan, Chief Technology Officer at Candel Therapeutics, Inc. (CADL), sold 40,784 shares at $4.56 ($186K) on 2024-11-29, disclosed to the SEC on 2024-12-03.
Open-market sale of $186k CADL by Chief Technology Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.56 | 20,392 | $93K | 50.0% |
| 2 | $4.56 | 20,392 | $93K | 50.0% |
| Total | $4.56 avg | 40,784 | $186K | 100% |
| Filing → |
| CADL | SELL | 2025-03-20 | $552K | — | Filing → |
| CADL | SELL | 2025-01-17 | $207K | — | Filing → |
| CADL | SELL | 2025-01-10 | $239K | — | Filing → |